4.7 Article

Association of PAI-1 and Fibrinogen With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT)

Related references

Note: Only part of the references are listed.
Editorial Material Endocrinology & Metabolism

PAI-1 and Diabetes: A Journey From the Bench to the Bedside

David J. Schneider et al.

DIABETES CARE (2012)

Article Endocrinology & Metabolism

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

Joanne W. Y. Yau et al.

DIABETES CARE (2012)

Article Endocrinology & Metabolism

Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT)

Nicholas Emanuele et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2009)

Article Medicine, General & Internal

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

William Duckworth et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications

C Erem et al.

MEDICAL PRINCIPLES AND PRACTICE (2005)

Review Medicine, General & Internal

Pivotal role of plasminogen-activator inhibitor 1 in vascular disease

M Agirbasli

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)

Article Endocrinology & Metabolism

Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2 Veterans Affairs Diabetes Trial

C Abraira et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2003)

Article Endocrinology & Metabolism

Diabetic retinopathy

DS Fong et al.

DIABETES CARE (2003)